Literature DB >> 20944902

Adverse mucocutaneous reactions to chemotherapeutic agents: part I.

Jose Antonio Sanches Junior1, Hebert Roberto Clivati Brandt, Emanuella Rosyane Duarte Moure, Guilherme Luiz Stelko Pereira, Paulo Ricardo Criado.   

Abstract

The local and systemic treatment of tumors can cause changes in the skin, mucous membranes, hair and nails. Accurate diagnosis and appropriate treatment of side effects require knowledge about the patterns of the most common adverse reactions to drugs the patient may be using. The dermatologist must be familiar with the manifestations of certain soft tissue neoplasms, as well as with the adverse mucocutaneous forms of cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20944902     DOI: 10.1590/s0365-05962010000400003

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


  6 in total

1.  Do you know this syndrome? Hand-foot syndrome.

Authors:  Cintia Santos Braghiroli; Rodrigo Ieiri; Juliana Polizel Ocanha; Rafael Bispo Paschoalini; Hélio Amante Miot
Journal:  An Bras Dermatol       Date:  2017 Jan-Feb       Impact factor: 1.896

2.  Evaluation of cutaneous side-effects associated with chemotherapeutic use in oncological patients.

Authors:  Zeynep Utlu; Handan Bilen
Journal:  Postepy Dermatol Alergol       Date:  2021-10-22       Impact factor: 1.837

3.  BCc1, the novel antineoplastic nanocomplex, showed potent anticancer effects in vitro and in vivo.

Authors:  Somayeh Kalanaky; Maryam Hafizi; Saideh Fakharzadeh; Mohammad Vasei; Ladan Langroudi; Ehsan Janzamin; Seyed Mahmoud Hashemi; Maryam Khayamzadeh; Masoud Soleimani; Mohammad Esmaeil Akbari; Mohammad Hassan Nazaran
Journal:  Drug Des Devel Ther       Date:  2015-12-30       Impact factor: 4.162

4.  Prospective Observational Study of Adverse Drug Reactions of Anticancer Drugs Used in Cancer Treatment in a Tertiary Care Hospital.

Authors:  V K Saini; R K Sewal; Yusra Ahmad; B Medhi
Journal:  Indian J Pharm Sci       Date:  2015 Nov-Dec       Impact factor: 0.975

5.  Persistent docetaxel-induced supravenous erythematous eruption.

Authors:  Karina de Almeida Pinto Fernandes; Paulo Antônio Oldani Felix
Journal:  An Bras Dermatol       Date:  2015 Sep-Oct       Impact factor: 1.896

6.  Inhibitory effects of resveratrol analogs on mushroom tyrosinase activity.

Authors:  Danielle Cristina Zimmermann Franco; Gustavo Senra Gonçalves de Carvalho; Paula Rafaela Rocha; Raquel da Silva Teixeira; Adilson David da Silva; Nádia Rezende Barbosa Raposo
Journal:  Molecules       Date:  2012-10-09       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.